Drug discovery

#Artificial intelligence (AI) #Data automation #Drug discovery #Laboratory data #Webinar

Webinar: Enable AI-ready data with data automation

The adoption of AI/ML in life science R&D is hindered by the lack of high-quality, well-structured data and metadata, a challenge exacerbated by a proliferation of proprietary instrument data formats, siloed lab software applications, and the absence of wet lab-friendly data automation platforms. While some workflow-specific solutions exist, they are… Read More

Webinar date:
Supported by Benchling
#News

Synthetic DNA
#Drug discovery #Protein chemistry / Proteomics #Protein engineering #Synthetic biology #Synthetic DNA #Webinar

Webinar: Ensure rapid, efficient and streamlined in vitro workflows

A new webinar is now open for registration entitled ‘Using ENFINIA cell-free synthesised DNA for rapid protein expression and screening in the myTXTL cell-free system‘. Cell-free transcription-translation (TXTL) systems can be used for rapid and flexible protein expression and screening workflows, powering protein engineering and discovery, synthetic biology, AI-driven… Read More

Webinar date:
Supported by Elegen Bio
#News

#Artificial intelligence (AI) #Data automation #Drug discovery #Laboratory data

Enable AI-ready data with data automation

The adoption of AI/ML in life science R&D is hindered by the lack of high-quality, well-structured data and metadata, a challenge exacerbated by a proliferation of proprietary instrument data formats, siloed lab software applications, and the absence of wet lab-friendly data automation platforms. While some workflow-specific solutions exist, they are… Read More

Webinar date:
Supported by Benchling
#Webinars

Synthetic DNA
#Drug discovery #Protein chemistry / Proteomics #Protein engineering #Synthetic biology #Synthetic DNA

Using ENFINIA™ cell-free synthesised DNA for rapid protein expression and screening in the myTXTL® cell-free system

Cell-free transcription-translation (TXTL) systems can be used for rapid and flexible protein expression and screening workflows, powering protein engineering and discovery, synthetic biology, AI-driven approaches, biomanufacturing, and more. However, reliance on plasmid DNA templates for expression requires time-consuming cloning steps, limiting speed and efficiency. In this webinar, supported by Elegen,… Read More

Webinar date:
Supported by Elegen
#Webinars

#2025 predictions #Diagnostics #Drug discovery

Diagnostics: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, with a focus on technology, machine learning (ML) and artificial intelligence (AI), as well as neuroscience, cancer research and cell and gene therapy. Here, looking through a diagnostics lens.  Jackie… Read More

#Business & Investment #Exclusive Content #Trends & Analysis

Bone cancer
#Bone cancer #Cancer therapy #Chordoma #DNA #Drug discovery #Rare disease

New therapy to treat rare bone cancer chordoma

A paper published in Nature Communications by a team of researchers from Oxford and North Carolina provides structural insights into human brachyury DNA recognition and discovery of progressible binders for cancer therapy. Unpacking brachyury According to the paper’s abstract1, Brachyury is a transcription factor that affects tumour growth of the… Read More

#News

#Drug discovery

Webinar: Advance Your MASH Research with the Right Rodent Models

Discover how to optimise your MASH (formerly NASH) preclinical studies with a mouse model generation expert. Watch this Taconic Biosciences webinar to:  Learn best practices for model selection, cohort design, and translational relevance.  Explore a real-world case study on successful model application in MASH drug development.  Gain key strategies to… Read More

#Webinars

#Collaboration #Drug discovery #Mergers and acquisitions #Partnership

The new industry deals progressing drug discovery

New partnerships, acquisitions and collaborations are helping drug discovery companies to tackle some of the biggest problems facing the industry. These include patient access to cell and gene therapies, the development of DNA gene therapies, and the challenges surrounding GI clinical trials.  Delbert acquires injectable antibiotic from Bristol… Read More

#Business & Investment #News

#2025 predictions #Cell and gene therapy #Drug discovery

Cell and gene therapy: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, with a focus on technology, machine learning (ML) and artificial intelligence (AI), as well as neuroscience and cancer research. Here, looking at cell and gene therapy. For the last few… Read More

#Business & Investment #Exclusive Content #Trends & Analysis

#Absci #AI / data analytics / healthtech / informatics #Antibodies #Artificial intelligence (AI) #Drug discovery #Drug targets #Interview #Machine learning

New podcast: The continued evidence of AI’s drug discovery value

This is the latest episode of the free DDW narrated podcast, titled “The continued evidence of AI’s drug discovery value”, which covers two articles written for DDW Volume 24 – Issue 2, Spring 2023 of DDW. They are called: “How generative AI could improve drug discovery” and “Can… Read More

#News

#2025 predictions #Cancer #Cancer research #Drug discovery

Cancer burden and research: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, with a focus on technology, machine learning (ML) and artificial intelligence (AI), as well as neuroscience. Here, looking at cancer burden and research in the sector. Ahead of World Cancer Day… Read More

#Business & Investment #Cancer Research #Exclusive Content #Trends & Analysis

Lab Automation
#Automated liquid handling #Automation / robotics #Drug discovery #Lab automation #Lab equipment #Lab of the future #Survey

Report reveals scale of opportunity for automation suppliers

The vast majority (80%) of researchers are using automation in less than half of their laboratory processes, despite the hype around these technologies. This is one of the key findings of the DDW Research & Consultancy 2025 Research Report Purchasing in Drug Discovery Lab Automation:… Read More

#Editor's Choice #News

#2025 predictions #Drug discovery #Neuroscience

Neuroscience: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, this was with a focus on technology, machine learning (ML) and artificial intelligence (AI). Here, looking at the neuroscience sector. At the Society for Neuroscience’s annual meeting, Neuroscience 2024, both the… Read More

#Business & Investment #Exclusive Content #Trends & Analysis

#Artificial intelligence (AI) #Drug discovery

Webinar: The benefits of generative AI in drug discovery – Amazon Web Services (AWS) – 28.01.2025

It can take years, and cost billions, to get new drugs approved for clinical use, but technological advances are transforming drug discovery and development. The growing shift towards artificial intelligence (AI), including generative and predictive AI, can reduce the amount of time and money it takes to develop new… Read More

#Webinars

#Drug discovery

Webinar: Safeguarding Genetic Integrity in Preclinical Rodent Models

Join geneticist Bart Smits, PhD in this exclusive webinar as he outlines key considerations for designing and maintaining a robust mouse colony to support your preclinical research needs. Secure your spot to: Understand the impact of background strain and substrain on mutation expression. Explore effective… Read More

#Webinars